人福医药：2025年第三季度归属于上市公司股东的净利润同比增长11.56%

Core Insights - The company reported a revenue of 5,819,434,372.57 yuan for the third quarter of 2025, representing a year-on-year decline of 7.36% [1] - The net profit attributable to shareholders of the listed company was 533,909,783.83 yuan, showing a year-on-year increase of 11.56% [1] Financial Performance - Revenue for Q3 2025: 5.82 billion yuan, down 7.36% year-on-year [1] - Net profit for Q3 2025: 533.91 million yuan, up 11.56% year-on-year [1]